TransEnterix

$3.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.42 (+68.60%) Today
+$0.04 (+1.15%) As of 10:28 PM UTC after-hours

Why Robinhood?

You can buy or sell TransEnterix and other stocks, options, and ETFs commission-free!

About TRXC

TransEnterix Inc., also called TransEnterix, is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC. The listed name for TRXC is TransEnterix Inc.

CEO
Anthony Fernando
Employees
163
Headquarters
Morrisville, North Carolina
Founded
2006
Market Cap
293.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
63.04M
High Today
$4.01
Low Today
$2.51
Open Price
$2.75
Volume
208.63M
52 Week High
$4.01
52 Week Low
$0.28

Collections

TRXC Earnings

-$0.83
-$0.55
-$0.28
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, After Hours

You May Also Like

BBJP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure